Federal Register / Vol. 74, No. 45 / Tuesday, March 10, 2009 / Notices 10259 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility LoanRepayment Program, National 

Institutes of Health, HHS) 

Dated: March 3, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–4978 Filed 3–9–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health & Human 

Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel; Nervous System 

Molecular Mechanisms. 

Date: April 3, 2009. 

Time: 2:30 p.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6100 

Executive Boulevard, Room 5B01, Rockville, 

MD 20852 (Telephone Conference Call). 

Contact Person: Gopal M. Bhatnagar, PhD, 

Scientific Review Administrator, National 

Institute of Child Health and Human 

Development, National Institutes of Health, 

6100 Bldg Rm 5B01, Rockville, MD 20852, 

(301) 435–6889, bhatnagg@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: March 3, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–4981 Filed 3–9–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; 

Community Based Participatory Research. 

Date: March 25, 2009. 

Time: 2 p.m. to 4:30 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Telephone 

Conference Call). 

Contact Person: Aileen Schulte, PhD., 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Blvd, Room 6140, MSC 9608, 

Bethesda, MD 20892–9608, 301–443–1225, 

aschulte@mail.nih.gov 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; 

National Cooperative Drug Discovery 

Development Groups for the Treatment of 

Mental Disorders, Drug or Alcohol 

Addiction. 

Date: March 25, 2009. 

Time: 4 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Telephone 

Conference Call). 

Contact Person: Vinod Charles, PhD., 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Blvd., Room 6151, MSC 9606, 

Bethesda, MD 20892–9606, 301–443–1606. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; ITVC 

Conflicts. 

Date: April 1, 2009. 

Time: 11 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Telephone 

Conference Call). 

Contact Person: Enid Light, PhD., 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Boulevard, Room 6132, MSC 

9608, Bethesda, MD 20852–9608, 301–443– 

0322, elight@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.242, Mental Health Research 

Grants; 93.281, Scientist Development 

Award, Scientist Development Award for 

Clinicians, and Research Scientist Award; 

93.282, MentalHealth National Research 

Service Awards for Research Training, 

National Institutes of Health, HHS) 

Dated: March 3, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–4979 Filed 3–9–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Library of Medicine; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Library of 

Medicine Special Emphasis Panel, Loan 

Repayment Program (L30-L40) Review. 

Date: April 21, 2009. 

Time: 12 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Library of Medicine, 6705 

Rockledge Drive, Suite 301, Bethesda, MD 

20892 (Telephone Conference Call). 

Contact Person: Zoe E. Huang, M.D., 

Scientific Review Officer, Extramural 

10260 Federal Register / Vol. 74, No. 45 / Tuesday, March 10, 2009 / Notices 

Programs, National Library of Medicine, NIH, 

6705 Rockledge Drive, Suite 301, Bethesda, 

MD 20892–7968, (301) 594–4937, 

huangz@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.879, Medical Library 

Assistance, National Institutes of Health, 

HHS) 

Dated: March 3, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–4975 Filed 3–9–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

Periodically, the Substance Abuse and 

Mental Health Services Administration 

(SAMHSA) will publish a summary of 

information collection requests under 

OMB review, in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

Chapter 35). To request a copy of these 

documents, call the SAMHSA Reports 

Clearance Officer on (240) 276–1243. 

Proposed Project: Enhancing Substance 

Abuse Treatment Services To Address 

Hepatitis Infection Among Intravenous 

Drug Users Hepatitis Testing and 

Vaccine Tracking Form—In Use 

Without OMB Approval 

The Substance Abuse and Mental 

Health Services Administration’s 

(SAMHSA) Center for Substance Abuse 

Treatment (CSAT) is requesting an OMB 

approval of a Hepatitis Testing and 

Vaccine Tracking Form for the 

prevention of Viral Hepatitis in patients 

in designated OTPs. This form is similar 

to the Minority AIDS Initiative HIV 

Rapid Testing Clinical Form that 

received an emergency approval (OMB 

No. 0930–0295) in September 2008. 

This form will allow SAMHSA/CSAT 

to collect essential Clinical information 

that will be used for quality assurance, 

quality performance and product 

monitoring on approximately 264 Rapid 

Hepatitis C Test kits and 10,628 doses 

of hepatitis vaccine (Twinrix, HAV, or 

HBV). The above kits and vaccines will 

be provided to designated OTPs serving 

the minority population in their 

communities. The information collected 

on the Form will solicit and reflect the 

following information: 

• Demographics (age, gender, 

ethnicity) of designated OTP site. 

• History (screening) of Hepatitis C 

exposure. 

• Results of Rapid Hepatitis C Testing 

(Kit) and follow-up information. 

• Service provided (type of vaccine 

given) Divalent vaccine (Twinrix— 

combination HAV and HBV) or 

Monovalent vaccine (HAV or/and HBV). 

• Substance abuse treatment 

outcomes (information regarding the 

beginning, continuing or completion of 

vaccination series). 

• Type of referral services indicated 

(i.e., Gastroenterology, TB; Mental 

Health, Counseling, Reproductive/ 

Prenatal, etc.). 

This program is authorized under 

Section 509 of the Public Health Service 

(PHS) Act [42 U.S.C. 290bb-2]. 

The purpose of the form is to increase 

the screening and reporting of viral 

hepatitis in high risk minorities in 

OTPs. The information collected will 

allow SAMHSA to address the increased 

morbidity and mortality of hepatitis in 

minorities being treated for drug 

addiction. 

The SAMHSA/CSAT Hepatitis 

Testing and Vaccine Tracking Form 

would support quality of care, provide 

minimum but adequate clinical and 

product monitoring, and provide 

appropriate safeguards against fraud, 

waste and abuse of Federal funds. 

The table below reflects the 

annualized hourly burden. 

Number of respondents screened Responses/ 

respondent Burden hours Total burden hours 

50,000 .......................................................................................................................................... 1 0.05 2,500 

Written comments and 

recommendations concerning the 

proposed information collection should 

be sent by April 9, 2009 to: SAMHSA 

Desk Officer, Human Resources and 

Housing Branch, Office of Management 

and Budget, New Executive Office 

Building, Room 10235, Washington, DC 

20503; due to potential delays in OMB’s 

receipt and processing of mail sent 

through the U.S. Postal Service, 

respondents are encouraged to submit 

comments by fax to: 202–395–6974. 

Dated: February 27, 2009. 

Elaine Parry, 

Director, Office of Program Services. 

[FR Doc. E9–5029 Filed 3–9–09; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HOMELAND 

SECURITY 

U.S. Citizenship and Immigration 

Services 

Agency Information Collection 

Activities: Form I–102, Extension of a 

Currently Approved Information 

Collection; Comment Request 

ACTION: 60-Day Notice of Information 

Collection Under Review: Form I–102, 

Application for Replacement/Initial 

Nonimmigrant Arrival-Departure 

Document; OMB Control No. 1615– 

0079. 

The Department of Homeland 

Security, U.S. Citizenship and 

Immigration Services (USCIS) has 

submitted the following information 

collection request for review and 

clearance in accordance with the 

Paperwork Reduction Act of 1995. The 

information collection is published to 

obtain comments from the public and 

affected agencies. Comments are 

encouraged and will be accepted for 

sixty days until May 11, 2009. 

Written comments and suggestions 

regarding items contained in this notice, 

and especially with regard to the 

estimated public burden and associated 

response time should be directed to the 

Department of Homeland Security 

(DHS), USCIS, Chief, Regulatory 

Management Division, Clearance Office, 

111 Massachusetts Avenue, NW., Suite 

3008, Washington, DC 20529–2210. 

Comments may also be submitted to 

DHS via facsimile to 202–272–8352, or 

via e-mail at rfs.regs@dhs.gov. When 

submitting comments by e-mail, add the 

OMB Control Number 1615–0079 in the 

subject box. 

During this 60-day period USCIS will 

be evaluating whether to revise the 

Form I–102. Should USCIS decide to 

revise the Form I–102 it will advise the 

public when it publishes the 30-day 

notice in the Federal Register in 

accordance with the Paperwork 

Reduction Act. The public will then